All Title Author
Keywords Abstract

PLOS ONE  2012 

Active Evasion of CTL Mediated Killing and Low Quality Responding CD8+ T Cells Contribute to Persistence of Brucellosis

DOI: 10.1371/journal.pone.0034925

Full-Text   Cite this paper   Add to My Lib

Abstract:

Brucellosis is a common zoonotic disease that remains endemic in many parts of the world. Dissecting the host immune response during this disease provides insight as to why brucellosis is often difficult to resolve. We used a Brucella epitope specific in vivo killing assay to investigate the ability of CD8+ T cells to kill targets treated with purified pathogenic protein. Importantly, we found the pathogenic protein TcpB to be a novel effector of adaptive immune evasion by inhibiting CD8+ T cell killing of Brucella epitope specific target cells in mice. Further, BALB/c mice show active Brucella melitensis infection beyond one year, many with previously unreported focal infection of the urogenital area. A fraction of CD8+ T cells show a CD8+ Tmem phenotype of LFA-1hi, CD127hi, KLRG-1lo during the course of chronic brucellosis, while the CD8+ T cell pool as a whole had a very weak polyfunctional cytokine response with diminished co-expression of IFN-γ with TNFα and/or IL-2, a hallmark of exhaustion. When investigating the expression of these 3 cytokines individually, we observed significant IFN-γ expression at 90 and 180 days post-infection. TNFα expression did not significantly exceed or fall below background levels at any time. IL-2 expression did not significantly exceeded background, but, interestingly, did fall significantly below that of uninfected mice at 180 days post-infection. Brucella melitensis evades and blunts adaptive immunity during acute infection and our findings provide potential mechanisms for the deficit observed in responding CD8+ T cells during chronic brucellosis.

References

[1]  Mantur B, Amarnath SK, Shinde RS (2007) Review of clinical and laboratory features of human brucellosis. Indian J Med Microbiol 25: 188–202.
[2]  Montaraz J, Winter AJ (1986) Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice. Infect Immun 53: 245–251.
[3]  Ko J, Splitter GA (2003) Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin Microbiol Rev 16: 65–78.
[4]  Commander N, Brewer JM, Wren BW, Spencer SA, Macmillan AP, et al. (2010) Liposomal delivery of p-ialB and p-omp25 DNA vaccines improves immunogenicity but fails to provide full protection against B. melitensis challenge. Genet Vaccines Ther 8: 5.
[5]  Martirosyan A, Moreno E, Gorvel JP (2011) An evolutionary strategy for a stealthy intracellular Brucella pathogen. Immunol Rev 240: 211–234.
[6]  López-Go?i I, Moriyón I (2004) Brucella: molecular and cellular biology. Horizon Bioscience: Wymondham, England.
[7]  Capasso L (2002) Bacteria in two-millennia-old cheese, and related epizoonoses in Roman populations. J Infect 45: 122–127.
[8]  D'Anastasio R, Zipfel B, Moggi-Cecchi J, Stanyon R, Capasso L (2009) Possible brucellosis in an early hominin skeleton from sterkfontein, South Africa. PLoS ONE 4: e6439.
[9]  Celli J, Gorvel JP (2004) Organelle robbery: Brucella interactions with the endoplasmic reticulum. Curr Opin Microbiol 7: 93–97.
[10]  Baldwin C, Goenka R (2006) Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection? Crit Rev Immunol 26: 407–442.
[11]  Lapaque N, Forquet F, de Chastellier C, Mishal Z, Jolly G, et al. (2006) Characterization of Brucella abortus lipopolysaccharide macrodomains as mega rafts. Cell Microbiol 8: 197–206.
[12]  Al Dahouk S, Jubier-Maurin V, Scholz HC, Tomaso H, Karges W, et al. (2008) Quantitative analysis of the intramacrophagic Brucella suis proteome reveals metabolic adaptation to late stage of cellular infection. Proteomics 8: 3862–3870.
[13]  Radhakrishnan G, Yu Q, Harms JS, Splitter GA (2009) Brucella TIR Domain-containing Protein Mimics Properties of the Toll-like Receptor Adaptor Protein TIRAP. J Biol Chem 284: 9892–9898.
[14]  Radhakrishnan G, Splitter GA (2010) Biochemical and functional analysis of TIR domain containing protein from Brucella melitensis. Biochem Biophys Res Commun 397: 59–63.
[15]  Pappas G, Panagopoulou P, Christou L, Akritidis N (2006) Brucella as a biological weapon. Cell Mol Life Sci 63: 2229–2236.
[16]  Durward M, Harms J, Magnani DM, Eskra L, Splitter GA (2010) Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo. Infect Immun 78: 168–176.
[17]  Obar J, Lefrancois L (2010) Early events governing memory CD8+ T-cell differentiation. Int Immunol 22: 619–625.
[18]  Obar J, Lefrancois L (2010) Early signals during CD8 T cell priming regulate the generation of central memory cells. J Immunol 185: 263–272.
[19]  Lamkanfi M, Dixit VM (2010) Manipulation of host cell death pathways during microbial infections. Cell Host Microbe 8: 44–54.
[20]  Dornand J, Gross A, Lafont V, Liautard J, Oliaro J, et al. (2002) The innate immune response against Brucella in humans. Vet Microbiol 90: 383–394.
[21]  Barquero-Calvo E, Chaves-Olarte E, Weiss DS, Guzmán-Verri C, Chacón-Díaz C, et al. (2007) Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection. PloS ONE 2: e631.
[22]  Chen F, He Y (2009) Caspase-2 mediated apoptotic and necrotic murine macrophage cell death induced by rough Brucella abortus. PloS ONE 4: e6830.
[23]  Fooksman D, Shaikh SR, Boyle S, Edidin M (2009) Cutting edge: phosphatidylinositol 4,5-bisphosphate concentration at the APC side of the immunological synapse is required for effector T cell function. J Immunol 182: 5179–5182.
[24]  Arens R, Schoenberger SP (2010) Plasticity in programming of effector and memory CD8 T-cell formation. Immunol Rev 235: 190–205.
[25]  Suresh M, Whitmire JK, Harrington LE, Larsen CP, Pearson TC, et al. (2001) Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory. J Immunol 167: 5565–5573.
[26]  Singh A, Suresh M (2007) A role for TNF in limiting the duration of CTL effector phase and magnitude of CD8 T cell memory. J Leukoc Biol 82: 1201–1211.
[27]  Araki K, Turner AP, Shaffer VO, Gangappa S, Keller SA, et al. (2009) mTOR regulates memory CD8 T-cell differentiation. Nature 460: 108–112.
[28]  Araki K, Youngblood B, Ahmed R (2010) The role of mTOR in memory CD8 T-cell differentiation. Immunol Rev 235: 234–243.
[29]  Sallusto F, Lanzavecchia A, Araki K, Ahmed R (2010) From vaccines to memory and back. Immunity 33: 451–463.
[30]  Singh A, Jatzek A, Plisch EH, Srinivasan R, Svaren J, et al. (2010) Regulation of memory CD8 T-cell differentiation by cyclin-dependent kinase inhibitor p27Kip1. Mol Cell Biol 30: 5145–5159.
[31]  Cui W, Kaech SM (2010) Generation of effector CD8+ T cells and their conversion to memory T cells. Immunol Rev 236: 151–166.
[32]  Lin J, Somanathan S, Roy S, Calcedo R, Wilson JM (2010) Lung homing CTLs and their proliferation ability are important correlates of vaccine protection against influenza. Vaccine 28: 5669–5675.
[33]  Zanetti M, Castiglioni P, Ingulli E (2010) Principles of memory CD8 T-cells generation in relation to protective immunity. Adv Exp Med Biol 684: 108–125.
[34]  Slifka M, Whitton JL (2000) Antigen-specific regulation of T cell-mediated cytokine production. Immunity 12: 451–457.
[35]  Barber D, Wherry EJ, Masopust D, Zhu B, Allison JP, et al. (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682–687.
[36]  Freeman G, Wherry EJ, Ahmed R, Sharpe AH (2006) Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. J Exp Med 203: 2223–2227.
[37]  Mueller S, Ahmed R (2009) High antigen levels are the cause of T cell exhaustion during chronic viral infection. Proc Natl Acad Sci U S A 106: 8623–8628.
[38]  Rueda C, Marín ND, García LF, Rojas M (2010) Characterization of CD4 and CD8 T cells producing IFN-gamma in human latent and active tuberculosis. Tuberculosis 90: 346–353.
[39]  Darrah P, Patel DT, De Luca PM, Lindsay RW, Davey DF, et al. (2007) Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 13: 843–850.
[40]  Lee SJ, O'Donnell H, McSorley SJ (2010) B7-H1 (programmed cell death ligand 1) is required for the development of multifunctional Th1 cells and immunity to primary, but not secondary, Salmonella infection. J Immunol 185: 2442–2449.
[41]  Colmenero J, Suarez-Mu?oz MA, Queipo-Ortu?o MI, Reguera JM, Morata P (2002) Late reactivation of calcified granuloma in a patient with chronic suppurative brucellosis. Eur J Clin Microbiol Infect Dis 21: 897–899.
[42]  Franco M, Mulder M, Gilman RH, Smits HL (2007) Human brucellosis. Lancet Infect Dis 7: 775–786.
[43]  Vrioni G, Pappas G, Priavali E, Gartzonika C, Levidiotou S (2008) An eternal microbe: Brucella DNA load persists for years after clinical cure. Clin Infect Dis 46: e131–136.
[44]  Skendros P, Pappas G, Boura P (2011) Cell-mediated immunity in human brucellosis. Microbes Infect 13: 134–142.
[45]  Yang Q, Guan KL (2007) Expanding mTOR signaling. Cell Res 17: 666–681.
[46]  Markman B, Dienstmann R, Tabernero J (2010) Targeting the PI3K/Akt/mTOR pathway – beyond rapalogs. Oncotarget 1: 530–543.
[47]  Durward M, Harms J, Splitter GA (2010) Antigen specific in vivo killing assay using CFSE labeled target cells. J Vis Exp 45: e2250.
[48]  Kaech S, Tan JT, Wherry EJ, Konieczny BT, Surh CD, et al. (2003) Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nature Immunol 4: 1191–1198.
[49]  Joshi N, Cui W, Chandele A, Lee HK, Urso DR, et al. (2007) Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27: 281–295.
[50]  Sarkar S, Kalia V, Haining WN, Konieczny BT, Subramaniam S, et al. (2008) Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J Exp Med 205: 625–640.
[51]  Lefrancois L, Obar JJ (2010) Once a killer, always a killer: from cytotoxic T cell to memory cell. Immunol Rev 235: 206–218.
[52]  Yi J, Cox MA, Zajac AJ (2010) T-cell exhaustion: characteristics, causes and conversion. Immunology 129: 474–481.
[53]  Cox M, Zajac AJ (2010) Shaping successful and unsuccessful CD8 T cell responses following infection. J Biomed Biotechnol 2010. 159152 p.
[54]  Baldwin CL, Parent M (2002) Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infection. Vet Microbiol 90: 367–382.
[55]  Colmenero J, Reguera JM, Martos F, Sánchez-De-Mora D, Delgado M, et al. (1996) Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine 75: 195–211.
[56]  Titball R (2008) Vaccines against intracellular bacterial pathogens. Drug Discov Today 13: 596–600.
[57]  Sette A, Peters B (2007) Immune epitope mapping in the post-genomic era: lessons for vaccine development. Curr Opin Immunol 19: 106–110.
[58]  Purcell A, McCluskey J, Rossjohn J (2007) More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discov 6: 404–414.
[59]  Mora M, Donati C, Medini D, Covacci A, Rappuoli R (2006) Microbial genomes and vaccine design: refinements to the classical reverse vaccinology approach. Curr Opin Microbiol 9: 532–536.
[60]  Sette A, Fikes J (2003) Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. Curr Opin Immunol 15: 461–470.
[61]  Rappuoli R (2000) Reverse vaccinology. Curr Opin Microbiol 3: 445–450.
[62]  Oliveira S, Splitter GA (1995) CD8+ type 1 CD44hi CD45 RBlo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I- and class II-deficient mice. Eur J Immunol 25: 2551–2557.
[63]  Brand?o AP OF, Carvalho NB, Vieira LQ, Azevedo V, Macedo GC, et al. (2012) Host susceptibility to Brucella abortus infection is more pronounced in IFN-γ knockout than IL-12/β2-microglobulin double-deficient mice. Clin Dev Immunol 2012: 589494. Epub 582011 Dec 589411:
[64]  Ko J, Gendron-Fitzpatrick A, Ficht TA, Splitter GA (2002) Virulence criteria for Brucella abortus strains as determined by interferon regulatory factor 1-deficient mice. Infect immun 70: 7004–7012.
[65]  Murphy E, Sathiyaseelan J, Parent MA, Zou B, Baldwin CL (2001) Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology 103: 511–518.
[66]  Baldwin C, Jiang X, Fernandes DM (1993) Macrophage control of Brucella abortus: influence of cytokines and iron. Trends Microbiol 1: 99–104.
[67]  Stevens M, Pugh GW Jr, Tabatabai LB (1992) Effects of gamma interferon and indomethacin in preventing Brucella abortus infections in mice. Infect immun 60: 4407–4409.
[68]  Schurig G, Sriranganathan N, Corbel MJ (2002) Brucellosis vaccines: past, present and future. Vet microbiol 90: 479–496.
[69]  Leclerq S, Harms JS, Rosinha GM, Azevedo V, Oliveira SC (2002) Induction of a th1-type of immune response but not protective immunity by intramuscular DNA immunisation with Brucella abortus GroEL heat-shock gene. J Med Microbiol 51: 20–26.
[70]  Singh V, Gowthaman U, Jain S, Parihar P, Banskar S, et al. (2010) Coadministration of interleukins 7 and 15 with bacille Calmette-Guerin mounts enduring T cell memory response against Mycobacterium tuberculosis. J infect dis 202: 480–489.
[71]  Wherry E, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R (2003) Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 77: 4911–4927.
[72]  Wherry E, Ha SJ, Kaech SM, Haining WN, Sarkar S, et al. (2007) Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27: 670–684.
[73]  Fuller M, Zajac AJ (2003) Ablation of CD8 and CD4 T cell responses by high viral loads. J Immunol 170: 477–486.
[74]  Fuller M, Hildeman DA, Sabbaj S, Gaddis DE, Tebo AE, et al. (2005) Cutting edge: emergence of CD127high functionally competent memory T cells is compromised by high viral loads and inadequate T cell help. J Immunol 174: 5926–5930.
[75]  Zhou S, Ou R, Huang L, Price GE, Moskophidis D (2004) Differential tissue-specific regulation of antiviral CD8+ T-cell immune responses during chronic viral infection. J Virol 78: 3578–3600.
[76]  Fuller M, Khanolkar A, Tebo AE, Zajac AJ (2004) Maintenance, loss, and resurgence of T cell responses during acute, protracted, and chronic viral infections. J Immunol 172: 4204–4214.
[77]  Zajac A, Blattman JN, Murali-Krishna K, Sourdive DJ, Suresh M, et al. (1998) Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 188: 2205–2213.
[78]  Jiang X, Leonard B, Benson R, Baldwin , CL (1993) Macrophage control of Brucella abortus: role of reactive oxygen intermediates and nitric oxide. Cell Immunol 151: 309–319.
[79]  Jiang X, Baldwin CL (1993) Effects of cytokines on intracellular growth of Brucella abortus. Infect Immun 61: 124–134.
[80]  Makedonas G, Hutnick N, Haney D, Amick AC, Gardner J, et al. (2010) Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells. PLoS Pathogens 6: e1000798.
[81]  Chowdhury D, Lieberman J (2008) Death by a thousand cuts: granzyme pathways of programmed cell death. Annu Rev Immunol 26: 389–420.
[82]  High K, Prasad R, Marion CR, Schurig GG, Boyle SM, et al. (2007) Outcome and immune responses after Brucella abortus infection in young adult and aged mice. Biogerontology 8: 583–593.
[83]  Rafiei A, Ardestani SK, Kariminia A, Keyhani A, Mohraz M, et al. (2006) Dominant Th1 cytokine production in early onset of human brucellosis followed by switching towards Th2 along prolongation of disease. J Infect 53: 315–324.
[84]  Rajashekara G, Glover DA, Krepps M, Splitter GA (2005) Temporal analysis of pathogenic events in virulent and avirulent Brucella melitensis infections. Cell Microbiol 7: 1459–1473.
[85]  Magnani D, Harms JS, Durward MA, Splitter GA (2009) Nondividing but metabolically active gamma-irradiated Brucella melitensis is protective against virulent B. melitensis challenge in mice. Infect Immun 77: 5181–5189.
[86]  Ingulli E (2007) Tracing tolerance and immunity in vivo by CFSE-labeling of administered cells. Methods Mol Biol 380: 365–376.
[87]  Cox MA, Zajac AJ (2010) Shaping successful and unsuccessful CD8 T cell responses following infection. J Biomed Biotechnol 2010. 159152 p.

Full-Text

comments powered by Disqus